相关实验视频
Updated: May 5, 2026

07:59
Molecular Entanglement and Electrospinnability of Biopolymers
Published on: September 3, 2014
14.7K
短距离的分子序列是粉消化能力和酸盐封装大米珠的质感的驱动因素
Senbin Cao1,2, Cheng Li1
1Food & Nutritional Sciences Programme, School of Life Sciences, The Chinese University of Hong Kong, Shatin, China.
Journal of the science of food and agriculture
|June 5, 2024
概括
酸盐封装的米珠是为了改善质地和减缓粉消化而创建的. 特定的米品种产生了具有增强消化能力和更柔软的纹理的珠子,提供了有前途的食品创新.
科学领域:
- 食品科学 食品科学 食品科学
- 材料科学 材料科学 材料科学
- 生物化学 生物化学
背景情况:
- 米谷类类似物通常质地差,限制了消费者接受.
- 酸封装是一种已知的方法,可以降低粉在其他粉中的消化能力.
- 粉分子结构对酸盐封装类似物的影响尚不清楚.
研究的目的:
- 开发酸盐封装的米珠作为一种新的米粒类比物.
- 调查不同品种大米对粉消化能力和质感的影响.
- 探索这些类似物中分子结构,可消化性和质感之间的关系.
主要方法:
- 使用各种大米品种构建包装在酸盐中的大米珠.
- 评估粉的消化速度和质感特性 (硬度,粘度).
- 使用福利埃变换红外光谱学分析分子结构,以确定短距离无形区域和相对晶度.
主要成果:
- 包装在酸盐中的大米珠表现出广泛的粉消化率.
- 某些米品种 (苏北,南京) 产生的珠子的粉消化速度比原来的米粒慢.
- 所有的米珠都表现出比它们的父母米粒更柔软的质地.
- 粉的消化速度,硬度和粘性与短距离无形区域正相关,而不是相对晶度.
结论:
- 具有较高的短距离有序结构的米品种会产生消化较慢的粉和更柔软的纹理的珠子.
- 酸盐封装与明智的米品种选择相结合,可以创建改进的米谷类型.
- 这种方法提供了一个开发更健康的米制品的策略,具有理想的感官属性.
相关概念视频
Polymer Classification: Crystallinity
3.1K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
3.1K
Factors Influencing Drug Absorption: Physicochemical Parameters
1.3K
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
1.3K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
835
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
835
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
735
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
735
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336

